Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
JNJ
JNJ
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
JNJ News
Johnson & Johnson Ordered to Pay $250,000 Over Talc Powder Case
16h ago
Benzinga
Johnson & Johnson Stock Gains Attention with Price Target Increases
19h ago
Yahoo Finance
Johnson & Johnson Found Liable for Ovarian Cancer Case
1d ago
seekingalpha
Jury Finds Johnson & Johnson Liable for Cancer Death
1d ago
Newsfilter
Johnson & Johnson (JNJ.US) Executive Plans to Sell $10.13 Million in Common Stock via Form 144
1d ago
moomoo
PENNSYLVANIA JURY RULES JOHNSON & JOHNSON RESPONSIBLE FOR WOMAN'S OVARIAN CANCER, SAYS ATTORNEY FOR NATIONAL TALC PLAINTIFFS
1d ago
moomoo
Stock Market Experiences AI-Driven Collapse as Reality Prevails Once More.
1d ago
Barron's
Growth Prospects for the EGFR-NSCLC Market Analyzed
3d ago
Newsfilter
NIH Discontinues Low-Dose Rivaroxaban Trial Amid Safety Concerns
3d ago
Benzinga
Johnson & Johnson: Strong Performance Amid Challenges
4d ago
Fool
Gilead's Earnings Beat Expectations, Yet Stock Prices Are Falling.
4d ago
Barron's
Next-Gen CNS Assets Attract Investor Interest
4d ago
PRnewswire
Next-Gen CNS Assets Attract Investor Interest
4d ago
Newsfilter
Johnson & Johnson to Present at Barclays Healthcare Conference
5d ago
Newsfilter
5 Stocks and ETFs to Protect Your Portfolio Amid Market Fluctuations
5d ago
Marketbeat
Johnson & Johnson's OMNY-AF Study Shows 90% Freedom from Atrial Fibrillation
6d ago
Benzinga
Show More News
